Inventor · disambiguated record
Paul E. Morin
Also filed as: MORIN PAUL · MORIN PAUL E
22 granted patents·7 pending applications·242 citations·filing 2007–2023
95Inventor score
Top patents by PatentIndex Score
29 records- 0197US9434778B2Modified FGF-21 polypeptides comprising an internal deletion and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 6, 2016·31 cites·20 claims
- 0295US10406251B2PD-L1 binding polypeptides for imagingBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 10, 2019·15 cites·35 claims
- 0394US10189883B2Therapeutic uses of modified FGF-21 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 29, 2019·12 cites·20 claims
- 0494US9631004B2Modified FGF-21 polypeptides comprising an internal deletion and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 25, 2017·12 cites·17 claims
- 0594US9540424B2Serum albumin binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 10, 2017·27 cites·19 claims
- 0694US8969289B2Serum albumin binding moleculesGOSSELIN MICHAEL L·Filed 2011·Granted Mar 3, 2015·45 cites·33 claims
- 0793US10221438B2Serum albumin binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 5, 2019·12 cites·16 claims
- 0891US11173219B2PD-L1 binding polypeptides for imagingBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 16, 2021·4 cites·21 claims
- 0991US10934572B2Serum albumin binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 2, 2021·4 cites·16 claims
- 1091US10266578B2Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 23, 2019·9 cites·30 claims
- 1190US10377806B2Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 13, 2019·6 cites·30 claims
- 1289US11344639B2PET imaging with PD-L1 binding polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 31, 2022·4 cites·13 claims
- 1388US11248031B2Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 15, 2022·4 cites·22 claims
- 1487US8067201B2Methods for protein refoldingMORIN PAUL·Filed 2010·Granted Nov 29, 2011·56 cites·27 claims
- 1581US11623965B2Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 11, 2023·1 cites·11 claims
- 1680US12247058B2Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 11, 2025·0 cites·21 claims
- 1779US12097242B2Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 24, 2024·0 cites·26 claims
- 1878US12097241B2Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 24, 2024·0 cites·17 claims
- 1975US11364281B2Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jun 21, 2022·0 cites·2 claims
- 2074US12194110B2PD-L1 binding polypeptides for imagingBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jan 14, 2025·0 cites·15 claims
- 2174US11185570B2Method of treating cardiovascular disease and heart failure with modified relaxin polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 2271US2023295346A1Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2366US2022347324A1Pet imaging with pd-l1 binding polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2463US11623013B2Methods and compositions for deuterated biologicsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 11, 2023·0 cites·18 claims
- 2556US2019099506A1Methods and compositions for deuterated biologicsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 2652US2022251206A1Anti-ctla4 antibody prodruggable (probody) at a cdr positionBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2751US2024277878A1Radiolabeled fibronectin based scaffolds and antibodies and theranostic uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2849US2023087600A1Il-10 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2942US2007149763A1Beta secretase exosite binding peptides and methods for identifying beta secretase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul E. Morin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →